Titre : Résultat thérapeutique

Résultat thérapeutique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Epidemiological Models
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Résultat thérapeutique : Questions médicales les plus fréquentes", "headline": "Résultat thérapeutique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Résultat thérapeutique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Résultat thérapeutique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Évaluation de résultat (soins)", "url": "https://questionsmedicales.fr/mesh/D017063", "about": { "@type": "MedicalCondition", "name": "Évaluation de résultat (soins)", "code": { "@type": "MedicalCode", "code": "D017063", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Arrêt précoce d'essais cliniques", "alternateName": "Early Termination of Clinical Trials", "url": "https://questionsmedicales.fr/mesh/D057239", "about": { "@type": "MedicalCondition", "name": "Arrêt précoce d'essais cliniques", "code": { "@type": "MedicalCode", "code": "D057239", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.379" } } }, { "@type": "MedicalWebPage", "name": "Évaluation de la réponse des tumeurs solides aux traitements", "alternateName": "Response Evaluation Criteria in Solid Tumors", "url": "https://questionsmedicales.fr/mesh/D066066", "about": { "@type": "MedicalCondition", "name": "Évaluation de la réponse des tumeurs solides aux traitements", "code": { "@type": "MedicalCode", "code": "D066066", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.569" } } }, { "@type": "MedicalWebPage", "name": "Réponse virologique soutenue", "alternateName": "Sustained Virologic Response", "url": "https://questionsmedicales.fr/mesh/D000072230", "about": { "@type": "MedicalCondition", "name": "Réponse virologique soutenue", "code": { "@type": "MedicalCode", "code": "D000072230", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.665" } } }, { "@type": "MedicalWebPage", "name": "Index thérapeutique", "alternateName": "Therapeutic Index", "url": "https://questionsmedicales.fr/mesh/D000076162", "about": { "@type": "MedicalCondition", "name": "Index thérapeutique", "code": { "@type": "MedicalCode", "code": "D000076162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.713" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Index thérapeutique du médicament", "alternateName": "Therapeutic Index, Drug", "url": "https://questionsmedicales.fr/mesh/D000074389", "about": { "@type": "MedicalCondition", "name": "Index thérapeutique du médicament", "code": { "@type": "MedicalCode", "code": "D000074389", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.713.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Échec thérapeutique", "alternateName": "Treatment Failure", "url": "https://questionsmedicales.fr/mesh/D017211", "about": { "@type": "MedicalCondition", "name": "Échec thérapeutique", "code": { "@type": "MedicalCode", "code": "D017211", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.760" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Échec des secours (soins de santé)", "alternateName": "Failure to Rescue, Health Care", "url": "https://questionsmedicales.fr/mesh/D000067248", "about": { "@type": "MedicalCondition", "name": "Échec des secours (soins de santé)", "code": { "@type": "MedicalCode", "code": "D000067248", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.760.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Résultat thérapeutique", "alternateName": "Treatment Outcome", "code": { "@type": "MedicalCode", "code": "D016896", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Peter S Rose", "url": "https://questionsmedicales.fr/author/Peter%20S%20Rose", "affiliation": { "@type": "Organization", "name": "Clinic Department of Orthopedic Surgery, Rochester, Minnesota, USA." } }, { "@type": "Person", "name": "Matthew T Houdek", "url": "https://questionsmedicales.fr/author/Matthew%20T%20Houdek", "affiliation": { "@type": "Organization", "name": "Clinic Department of Orthopedic Surgery, Rochester, Minnesota, USA." } }, { "@type": "Person", "name": "Pim B Olthof", "url": "https://questionsmedicales.fr/author/Pim%20B%20Olthof", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: p.olthof@erasmusmc.nl." } }, { "@type": "Person", "name": "Stijn Franssen", "url": "https://questionsmedicales.fr/author/Stijn%20Franssen", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Trend of gastric cancer incidence and death rate in adolescents and young adults: A retrospective cohort study based on the Surveillance, Epidemiology, and End Results (SEER) database.", "datePublished": "2022-11-28", "url": "https://questionsmedicales.fr/article/36403128", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jgh.16064" } }, { "@type": "ScholarlyArticle", "name": "Clinical, genetic, and epidemiological survey of Polish children and adolescents with severe obesity: A study protocol of the Polish-German study project on severe early-onset obesity.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36479220", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2022.972174" } }, { "@type": "ScholarlyArticle", "name": "Corrigendum: The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose-response meta-analysis of epidemiological studies involving 160,727 patients.", "datePublished": "2022-11-08", "url": "https://questionsmedicales.fr/article/36441605", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fonc.2022.1072594" } }, { "@type": "ScholarlyArticle", "name": "What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019.", "datePublished": "2022-11-02", "url": "https://questionsmedicales.fr/article/36374576", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/CORR.0000000000002465" } }, { "@type": "ScholarlyArticle", "name": "Association of Patients' Epidemiological Characteristics and Comorbidities with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of an Umbrella Systematic Review and Meta-Analysis.", "datePublished": "2022-09-29", "url": "https://questionsmedicales.fr/article/36289699", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/biomedicines10102437" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Qualité, accès, évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017530" }, { "@type": "ListItem", "position": 3, "name": "Qualité des soins de santé", "item": "https://questionsmedicales.fr/mesh/D011787" }, { "@type": "ListItem", "position": 4, "name": "Mécanismes d'évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017531" }, { "@type": "ListItem", "position": 5, "name": "Évaluation des résultats et des processus en soins de santé", "item": "https://questionsmedicales.fr/mesh/D010043" }, { "@type": "ListItem", "position": 6, "name": "Évaluation de résultat (soins)", "item": "https://questionsmedicales.fr/mesh/D017063" }, { "@type": "ListItem", "position": 7, "name": "Résultat thérapeutique", "item": "https://questionsmedicales.fr/mesh/D016896" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Résultat thérapeutique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Résultat thérapeutique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Résultat thérapeutique", "description": "Comment évaluer l'efficacité d'un traitement ?\nQuels outils mesurent les résultats thérapeutiques ?\nQu'est-ce qu'un critère de jugement ?\nComment les résultats sont-ils rapportés ?\nQuelle est l'importance des études de suivi ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Epidemiological+Models&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Résultat thérapeutique", "description": "Quels symptômes indiquent un bon résultat thérapeutique ?\nComment les symptômes peuvent-ils masquer les résultats ?\nLes symptômes peuvent-ils réapparaître après un traitement ?\nComment les symptômes influencent-ils le traitement ?\nQuels sont les symptômes d'une réponse négative au traitement ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Epidemiological+Models&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Résultat thérapeutique", "description": "Comment prévenir les échecs thérapeutiques ?\nQuel rôle joue l'éducation du patient ?\nLes vaccinations influencent-elles les résultats ?\nComment le mode de vie affecte-t-il les résultats ?\nQuelles sont les stratégies de prévention des complications ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Epidemiological+Models&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Résultat thérapeutique", "description": "Quels traitements montrent de bons résultats ?\nComment personnaliser un traitement pour de meilleurs résultats ?\nQuel rôle joue l'adhésion au traitement ?\nLes traitements alternatifs sont-ils efficaces ?\nComment évaluer les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Epidemiological+Models&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Résultat thérapeutique", "description": "Quelles complications peuvent survenir après un traitement ?\nComment évaluer les complications d'un traitement ?\nLes complications affectent-elles les résultats ?\nComment prévenir les complications liées au traitement ?\nQuelles sont les complications à long terme des traitements ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Epidemiological+Models&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Résultat thérapeutique", "description": "Quels facteurs de risque influencent les résultats ?\nComment les comorbidités affectent-elles les résultats ?\nLe mode de vie influence-t-il les résultats ?\nComment l'âge impacte-t-il les résultats ?\nLes facteurs psychologiques influencent-ils les résultats ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Epidemiological+Models&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'efficacité d'un traitement ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité se mesure par l'amélioration des symptômes et des résultats cliniques." } }, { "@type": "Question", "name": "Quels outils mesurent les résultats thérapeutiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles de mesure, des questionnaires et des biomarqueurs sont utilisés." } }, { "@type": "Question", "name": "Qu'est-ce qu'un critère de jugement ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "C'est un indicateur utilisé pour évaluer l'efficacité d'un traitement dans les études cliniques." } }, { "@type": "Question", "name": "Comment les résultats sont-ils rapportés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les résultats sont souvent rapportés sous forme de pourcentages d'amélioration ou de scores." } }, { "@type": "Question", "name": "Quelle est l'importance des études de suivi ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'évaluer la durabilité des résultats thérapeutiques sur le long terme." } }, { "@type": "Question", "name": "Quels symptômes indiquent un bon résultat thérapeutique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une réduction des symptômes, comme la douleur ou la fatigue, indique un bon résultat." } }, { "@type": "Question", "name": "Comment les symptômes peuvent-ils masquer les résultats ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes persistants peuvent donner l'impression d'un traitement inefficace, même si des améliorations sont présentes." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils réapparaître après un traitement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains symptômes peuvent réapparaître, nécessitant une réévaluation du traitement." } }, { "@type": "Question", "name": "Comment les symptômes influencent-ils le traitement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes guident les ajustements de traitement pour optimiser les résultats." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une réponse négative au traitement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une aggravation des symptômes ou l'apparition de nouveaux symptômes peuvent indiquer une réponse négative." } }, { "@type": "Question", "name": "Comment prévenir les échecs thérapeutiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation régulière et des ajustements de traitement peuvent prévenir les échecs." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation du patient ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation aide les patients à comprendre leur traitement et à améliorer leur adhésion." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les résultats ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent prévenir des complications et améliorer les résultats globaux." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il les résultats ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut améliorer les résultats thérapeutiques en renforçant la santé globale." } }, { "@type": "Question", "name": "Quelles sont les stratégies de prévention des complications ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les stratégies incluent le suivi régulier, l'éducation et l'adaptation des traitements." } }, { "@type": "Question", "name": "Quels traitements montrent de bons résultats ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements basés sur des preuves, comme les médicaments et la thérapie physique, montrent souvent de bons résultats." } }, { "@type": "Question", "name": "Comment personnaliser un traitement pour de meilleurs résultats ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La personnalisation se fait en tenant compte des caractéristiques individuelles du patient et de sa réponse au traitement." } }, { "@type": "Question", "name": "Quel rôle joue l'adhésion au traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne adhésion au traitement est cruciale pour atteindre des résultats thérapeutiques optimaux." } }, { "@type": "Question", "name": "Les traitements alternatifs sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements alternatifs peuvent être efficaces, mais leur efficacité doit être évaluée scientifiquement." } }, { "@type": "Question", "name": "Comment évaluer les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires sont évalués par des rapports de patients et des études cliniques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après un traitement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections ou des effets secondaires peuvent survenir après un traitement." } }, { "@type": "Question", "name": "Comment évaluer les complications d'un traitement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont évaluées par des examens cliniques et des rapports de patients." } }, { "@type": "Question", "name": "Les complications affectent-elles les résultats ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent altérer les résultats thérapeutiques et nécessiter des ajustements." } }, { "@type": "Question", "name": "Comment prévenir les complications liées au traitement ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un suivi régulier et une gestion proactive des effets secondaires." } }, { "@type": "Question", "name": "Quelles sont les complications à long terme des traitements ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent persister, comme des douleurs chroniques ou des troubles fonctionnels." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent les résultats ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, le sexe et les comorbidités peuvent influencer les résultats thérapeutiques." } }, { "@type": "Question", "name": "Comment les comorbidités affectent-elles les résultats ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les comorbidités peuvent compliquer le traitement et altérer les résultats globaux." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les résultats ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines peuvent améliorer les résultats thérapeutiques." } }, { "@type": "Question", "name": "Comment l'âge impacte-t-il les résultats ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "L'âge peut affecter la réponse au traitement et la tolérance aux effets secondaires." } }, { "@type": "Question", "name": "Les facteurs psychologiques influencent-ils les résultats ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme le stress et l'anxiété peuvent affecter l'adhésion et les résultats thérapeutiques." } } ] } ] }

Sources (10000 au total)

Trend of gastric cancer incidence and death rate in adolescents and young adults: A retrospective cohort study based on the Surveillance, Epidemiology, and End Results (SEER) database.

Less attentions are paid into the adolescents and young adults (AYAs) diagnosed with gastric cancer (GC). Our study aims to explore incidence rate trend, death rate trend, and prognostic factors for o... A retrospective cohort study based on the Surveillance, Epidemiology, and End Results (SEER) database was performed. Joinpoint regression analysis was used to calculate average annual percent change (... Although no statistical significance, incidence rate trend showed a tendency to an increase in AYAs (AAPC = 0.2, 95% CI: -0.2-0.6). All-cause death rate trends were declined both in AYAs and middle-ag... AYAs had a higher risk of GC-specific death, indicating more attention should be paid into AYAs with GC....

Clinical, genetic, and epidemiological survey of Polish children and adolescents with severe obesity: A study protocol of the Polish-German study project on severe early-onset obesity.

Severe early-onset obesity (SEOO) in children is a common feature of monogenic obesity. Nowadays, mutations in at least 50 genes are known to be related to monogenic obesity, and many others are teste...

What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019.

Hip fractures are associated with a high risk of death; among those who survive a hip fracture, many experience substantial decreases in quality of life. A comprehensive understanding of the epidemiol... Using data from the GBD 2019, we asked, (1) What are the global, regional, and national incidences of hip fractures, and how did they change over a recent 30-year span? (2) What is the global, regiona... This was a cross-sectional study. Participant data were obtained from the GBD 2019 ( http://ghdx.healthdata.org/gbd-results-tool ). The GBD study is managed by the WHO, coordinated by the Institute of... Globally, hip fracture incidences were estimated to be 14.2 million (95% UI 11.1 to 18.1), and the associated years lived with disability were 2.9 million (95% UI 2.0 to 4.0) in 2019, with an incidenc... Hip fractures are common, devastating to patients, and economically burdensome to healthcare systems globally, with falls being the leading cause. The age-standardized incidence rate has slightly incr... Level III, prognostic study....

Retrospective Cohort Study of the 12-Month Epidemiology, Treatment Patterns, Outcomes, and Health Care Costs Among Adult Patients With Complicated Urinary Tract Infections.

Limited data are available in the United States on the 12-month epidemiology, outpatient (OP) antibiotic treatment patterns, outcomes, and costs associated with complicated urinary tract infections (c... A retrospective observational cohort study of adult patients with incident cUTIs in IBM MarketScan Databases between 2017 and 2019 was performed. Patients were categorized as OP or inpatient (IP) base... During the study period, 95 322 patients met inclusion criteria. Most patients were OPs (84%) and age <65 years (87%). Treatment failure (receipt of new unique OP antibiotic or cUTI-related ED visit/I... These findings highlight the substantial 12-month health care burden associated with cUTIs and underscore the need for new outpatient treatment approaches that reduce the persistent or recurrent natur...

Epidemiologic and clinical features of cyanobacteria harmful algal bloom exposures reported to the National Poison Data System, United States, 2010-2022: a descriptive analysis.

Harmful algal bloom occurrences have been increasingly reported globally and over time. Exposure to the variety of toxins and co-contaminants that may be present in harmful algal blooms can cause illn... The objective of this study was to characterize epidemiologic and clinical features of cyanoHAB exposure cases reported to 55 US poison control centers and available in the National Poison Data System... Over half of cyanoHAB exposure cases were children < 20 years old (n = 2175). Most cyanoHABs exposures occurred in a "public area" (n = 2902, 68.1%); most were acute (≤ 8 h) (n = 3824, 89.8%). Dermal ... CyanoHAB exposure case rates increased 2010-2022, despite a decrease in all-cause exposure cases during the same period. NPDS data provide valuable public health information for characterization of cy...

A Comparison of Green, Delta, and Monte Carlo Methods to Select an Optimal Approach for Calculating the 95% Confidence Interval of the Population-attributable Fraction: Guidance for Epidemiological Research.

This study aimed to compare the Delta, Greenland, and Monte Carlo methods for estimating 95% confidence intervals (CIs) of the population-attributable fraction (PAF). The objectives were to identify t... A dataset was simulated using hypothetical values for primary parameters (population, relative risk [RR], prevalence, and variance of the beta estimator [V(β ̂)]) involved in PAF calculations. Three m... No significant differences were observed among the 3 methods when both the RR and p-value were low. The Delta method performed well under conditions of low prevalence or minimal RR, while Greenland's ... This study emphasizes the necessity of a careful approach for comparing 95% CI estimation methods for PAFs and selecting the method that best suits the context. It provides practical guidelines to res...

Anterior Cruciate Ligament Ruptures in Russian Premier League Soccer Players During the 2010 to 2021/2022 Competitive Seasons: The Epidemiology and Details of Return to Sports.

There are limited data on the epidemiology of anterior cruciate ligament (ACL) ruptures in elite adult soccer players, especially in the Russian Premier League (RPL). There is an increased risk of inj... To study the epidemiology of ACL ruptures and determine the patterns associated with their occurrence in RPL soccer players.... Descriptive epidemiology study.... All ACL ruptures requiring surgery sustained by players competing in the RPL across 12 competitive seasons between 2010 and 2022 were analyzed. All required data were collected from media analysis and... A total of 85 players sustained 100 injuries during 12 competitive seasons. A total of 96.5% of players returned to competitive play. The injury incidence in RPL and during participation of RPL teams ... RPL ACL injury epidemiology is similar to that in the other leagues from around the world, although there are factors that can potentially influence the number of these injuries....